{"id":15329,"date":"2021-10-20T19:35:24","date_gmt":"2021-10-20T23:35:24","guid":{"rendered":"https:\/\/www.drugpatentwatch.com\/blog\/?p=15329"},"modified":"2025-07-09T23:06:44","modified_gmt":"2025-07-10T03:06:44","slug":"drugpatentwatch-ranked-best-biopharmaceuticals-commercial-business-intelligence-platform","status":"publish","type":"post","link":"https:\/\/www.drugpatentwatch.com\/blog\/drugpatentwatch-ranked-best-biopharmaceuticals-commercial-business-intelligence-platform\/","title":{"rendered":"DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform"},"content":{"rendered":"\n
\"DrugPatentWatch<\/figure>\n\n\n\n

We\u2019re pleased to share that DrugPatentWatch<\/strong> has been recognized as the Best Biopharmaceuticals Commercial Business Intelligence Platform<\/strong> by Global Health & Pharma (GHP) News<\/em> as part of their International Life Sciences Awards.<\/p>\n\n\n\n

This award reflects our commitment to providing high-quality, actionable information to professionals across the pharmaceutical and life sciences industries. The recognition highlights the ongoing value we aim to deliver in helping companies navigate complex patent landscapes and make more informed business decisions.<\/p>\n\n\n\n

About the Award<\/h3>\n\n\n\n

The International Life Sciences Awards, hosted annually by GHP News, recognize organizations that are making meaningful contributions to the life sciences sector. Winners are selected based on merit, considering innovation, client satisfaction, and industry impact. DrugPatentWatch was selected for its role in supporting business development, competitive intelligence, and regulatory strategy with a focus on intellectual property.<\/p>\n\n\n\n

What DrugPatentWatch Offers<\/h3>\n\n\n\n

DrugPatentWatch is built to serve a wide range of stakeholders in the pharmaceutical value chain. These include:<\/p>\n\n\n\n

    \n
  • Branded pharmaceutical firms<\/strong> managing lifecycle planning and market exclusivity<\/li>\n\n\n\n
  • Generic manufacturers<\/strong> evaluating opportunities to enter markets as patents expire<\/li>\n\n\n\n
  • API suppliers<\/strong> seeking to align production timelines with generic launches<\/li>\n\n\n\n
  • Health insurers and payers<\/strong> forecasting drug availability and costs<\/li>\n\n\n\n
  • Legal and regulatory teams<\/strong> tracking patent disputes and settlements<\/li>\n<\/ul>\n\n\n\n

    By providing structured data on drug patents, exclusivity periods, litigation, and regulatory filings, DrugPatentWatch helps organizations make decisions based on clear, current, and comprehensive information.<\/p>\n\n\n\n

    How Organizations Use It<\/h3>\n\n\n\n

    Our subscribers use DrugPatentWatch for a variety of tasks, including:<\/p>\n\n\n\n

      \n
    • Monitoring upcoming patent expirations<\/li>\n\n\n\n
    • Planning entry strategies for generics and biosimilars<\/li>\n\n\n\n
    • Conducting competitive intelligence<\/li>\n\n\n\n
    • Tracking Paragraph IV challenges and other litigation<\/li>\n\n\n\n
    • Assessing the commercial landscape around specific drugs<\/li>\n<\/ul>\n\n\n\n

      Unlike many traditional market research tools, DrugPatentWatch emphasizes direct data access. We support integrations and automation to help our users incorporate our information into internal workflows, dashboards, or decision models.<\/p>\n\n\n\n

      Recognition That Reflects User Impact<\/h3>\n\n\n\n

      While this award is appreciated, what matters most is how our platform is used in practice. From Fortune 500 companies to early-stage startups, DrugPatentWatch supports day-to-day decisions that affect drug development, pricing, market entry, and more. We\u2019re proud to be part of the infrastructure that helps move new treatments forward and keeps drug prices transparent.<\/p>\n\n\n\n

      Looking Ahead<\/h3>\n\n\n\n

      This recognition reaffirms our focus on providing reliable, practical business intelligence for the biopharmaceutical sector. We\u2019re continuing to expand our coverage, improve usability, and offer new tools to meet the evolving needs of our users.<\/p>\n\n\n\n

      For those already using DrugPatentWatch, thank you for your support and feedback. For those considering it, we welcome the opportunity to learn more about your needs and explore how we can help.<\/p>\n\n\n\n

       <\/p>\n","protected":false},"excerpt":{"rendered":"

      We\u2019re pleased to share that DrugPatentWatch has been recognized as the Best Biopharmaceuticals Commercial Business Intelligence Platform by Global Health […]<\/p>\n","protected":false},"author":1,"featured_media":15331,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10,6],"tags":[],"class_list":["post-15329","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights","category-update"],"modified_by":"DrugPatentWatch","_links":{"self":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/15329","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/comments?post=15329"}],"version-history":[{"count":1,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/15329\/revisions"}],"predecessor-version":[{"id":33203,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/15329\/revisions\/33203"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media\/15331"}],"wp:attachment":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media?parent=15329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/categories?post=15329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/tags?post=15329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}